Search research articles
Contact Us
Filters
Showing results (231-240 of 385) with videos related to
Page
of 39
Sort By:
Journal of Natural Products
|
January 1, 1995
A new subclass of alkaloids from a dendrobatid poison frog: a structure for deoxypumiliotoxin 251H
P Jain, H M Garraffo, T F Spande, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 1, 1981
Adenosine receptors and behavioral actions of methylxanthines
S H Snyder, J J Katims, Z Annau, et al.
Journal of Chemical Ecology
|
November 19, 2013
Dietary source for skin alkaloids of poison frogs (Dendrobatidae)?
J W Daly, H Martin Garraffo, T F Spande, et al.
Biochemical Pharmacology
|
March 7, 1997
Pseudophrynaminol: a potent noncompetitive blocker of nicotinic receptor-channels
B Badio, H M Garraffo, W L Padgett, et al.
Drug Development Research
|
July 10, 2012
Riboflavin: Inhibitory Effects on Receptors, G-Proteins, and Adenylate Cyclase
John W Daly, Dan Shi, William L Padgett, et al.
Neurochemical Research
|
April 1, 1991
Nicotinic receptor-elicited sodium flux in rat pheochromocytoma PC12 cells: effects of agonists, antagonists, and noncompetitive blockers
J W Daly, Y Nishizawa, M W Edwards, et al.
Journal of Medicinal Chemistry
|
March 1, 1983
Structure-activity relationships for activation of adenylate cyclase by the diterpene forskolin and its derivatives
K B Seamon, J W Daly, H Metzger, et al.
Beilstein Journal of Organic Chemistry
|
January 23, 2008
Facile synthesis of two diastereomeric indolizidines corresponding to the postulated structure of alkaloid 5,9E-259B from a Bufonid toad (Melanophryniscus)
Angela Nelson, H Martin Garraffo, Thomas F Spande, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 1987
A1- and A2-selective adenosine antagonists: in vivo characterization of cardiovascular effects
G Evoniuk, K A Jacobson, M T Shamim, et al.
American Health & Drug Benefits
|
December 20, 2014
Evaluation of dabigatran for appropriateness of use and bleeding events in a community hospital setting
Anastasia L Armbruster, Katie S Buehler, Sun H Min, et al.
Page
of 39
Search research articles
Search
Showing results (231-240 of 385) with videos related to
Sort By:
Page
of 39
Journal of Natural Products
|
January 1, 1995
A new subclass of alkaloids from a dendrobatid poison frog: a structure for deoxypumiliotoxin 251H
P Jain, H M Garraffo, T F Spande, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 1, 1981
Adenosine receptors and behavioral actions of methylxanthines
S H Snyder, J J Katims, Z Annau, et al.
Journal of Chemical Ecology
|
November 19, 2013
Dietary source for skin alkaloids of poison frogs (Dendrobatidae)?
J W Daly, H Martin Garraffo, T F Spande, et al.
Biochemical Pharmacology
|
March 7, 1997
Pseudophrynaminol: a potent noncompetitive blocker of nicotinic receptor-channels
B Badio, H M Garraffo, W L Padgett, et al.
Drug Development Research
|
July 10, 2012
Riboflavin: Inhibitory Effects on Receptors, G-Proteins, and Adenylate Cyclase
John W Daly, Dan Shi, William L Padgett, et al.
Neurochemical Research
|
April 1, 1991
Nicotinic receptor-elicited sodium flux in rat pheochromocytoma PC12 cells: effects of agonists, antagonists, and noncompetitive blockers
J W Daly, Y Nishizawa, M W Edwards, et al.
Journal of Medicinal Chemistry
|
March 1, 1983
Structure-activity relationships for activation of adenylate cyclase by the diterpene forskolin and its derivatives
K B Seamon, J W Daly, H Metzger, et al.
Beilstein Journal of Organic Chemistry
|
January 23, 2008
Facile synthesis of two diastereomeric indolizidines corresponding to the postulated structure of alkaloid 5,9E-259B from a Bufonid toad (Melanophryniscus)
Angela Nelson, H Martin Garraffo, Thomas F Spande, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 1987
A1- and A2-selective adenosine antagonists: in vivo characterization of cardiovascular effects
G Evoniuk, K A Jacobson, M T Shamim, et al.
American Health & Drug Benefits
|
December 20, 2014
Evaluation of dabigatran for appropriateness of use and bleeding events in a community hospital setting
Anastasia L Armbruster, Katie S Buehler, Sun H Min, et al.
Page
of 39